...
首页> 外文期刊>Journal of medical systems >Covid-19 Imaging Tools: How Big Data is Big?
【24h】

Covid-19 Imaging Tools: How Big Data is Big?

机译:Covid-19成像工具:大数据如何大?

获取原文
获取原文并翻译 | 示例
           

摘要

In this paper, considering year 2020 and Covid-19, we analyze medical imaging tools and their performance scores in accordance with the dataset size and their complexity. For this, we mainly consider AI-driven tools that employ two different types of image data, namely chest Computed Tomography (CT) and X-ray. We elaborate on their strengths and weaknesses by taking the following important factors into account: i) dataset size; ii) model fitting criteria (over-fitting and under-fitting); iii) transfer learning in the deep learning era; and iv) data augmentation. Medical imaging tools do not explicitly analyze model fitting. Also, using transfer learning, with fewer data, one could possibly build Covid-19 deep learning model but they are limited to education and training. We observe that, in both image modalities, neither the dataset size nor does data augmentation work well for Covid-19 screening purposes because a large dataset does not guarantee all possible Covid-19 manifestations and data augmentation does not create new Covid-19 cases.
机译:本文考虑了2019冠状病毒疾病的2020年和COVID-19,根据数据集的大小和复杂性分析医学成像工具及其性能得分。为此,我们主要考虑采用两种不同类型的图像数据的人工智能驱动工具,即胸部计算机断层扫描(CT)和X射线。我们通过考虑以下重要因素详细阐述了它们的优缺点:i)数据集大小;ii)模型拟合标准(过拟合和欠拟合);iii)深度学习时代的迁移学习;iv)数据扩充。医学成像工具没有明确分析模型拟合。2019冠状病毒疾病的研究也较少,但使用迁移学习,数据较少,可以建立COVID-19深度学习模型,但限于教育和培训。在2019冠状病毒疾病2019冠状病毒疾病2019冠状病毒疾病中,我们观察到,在两种图像方式中,无论是数据集大小还是数据扩增都不能很好地用于COVID-19筛选目的,因为大数据集不能保证所有可能的COVID-19表现,并且数据扩增不会产生新的COVID-19病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号